(Q30400895)

English

Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

electroporation

1 reference

based on heuristic

inferred from title

author name string

Lei Tan

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Huijun Lu

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Dan Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Kaiyan Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Mingyao Tian

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Cunxia Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yanyu Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Bo Hu

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ningyi Jin

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Science in China. Series C: Life Sciences

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

293-299

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

describes a project that uses

electroporation

1 reference

based on heuristic

inferred from title

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Effective construction of DNA vaccines against variable influenza genes by homologous recombination.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Protection against influenza B virus infection by immunization with DNA vaccines.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Electroporation-based DNA immunisation: translation to the clinic

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Strategies to improve protection against low-pathogenicity H7 avian influenza virus infection using DNA vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Differential infection of receptor-modified host cells by receptor-specific influenza viruses

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4150-5

21 January 2018

Identifiers

10.1007/S11427-011-4150-5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30400895&oldid=2194820064"